MarketLens

What Does the FDA's NDA Acceptance Mean for Mineralys Therapeutics

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does Teva's Recent FDA Acceptance Mean for Investors

6 months ago

What Does the FDA's BLA Acceptance Mean for Inhibrx

2 months ago

What Does FDA Clearance Mean for AI-Powered Diagnostics

3 months ago

What Does Ultragenyx's Latest FDA Clearance Mean for Investors

4 months ago

Cadence's HypertensionOS Software Announced as Second Participant in FDA's TEMPO to Advance Hypertension Care

Cadence's HypertensionOS was selected as the second participant in the FDA's TEMPO pilot, a program for digital health devices. The AI-assisted prescription software supports clinician-supervised hype...

CDNS

Stock News•1 week ago

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Mineralys Therapeutics reported Q2 2026 results, with lorundrostat's PDUFA date set for December 22, 2026, and commercial preparations on track. The company strengthened its balance sheet via financin...

MLYS

Stock News•1 months ago

Can Novartis' Fabhalta Strengthen Its Nephrology Franchise?

Novartis won full FDA approval for Fabhalta in IgA nephropathy after phase III data showed slower kidney function decline, strengthening its nephrology portfolio.

NVS

Stock News•1 months ago

Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance

Axsome's NDA for AXS-12 in narcolepsy with cataplexy was accepted by the FDA, with a decision date set for May 2027.

AXS

Breaking News

View All →

Event-Driven Investing

Shareholder Rights

Top Headlines

View More →

Stock News•48 minutes ago

Between Amazon, Alphabet, and Meta, Microsoft is Most Likely to Deliver Best Free Cash Flow in 2026

Stock News•49 minutes ago

Amazon Web Services Backlog Reaches $496 Billion: Does That Make Amazon Stock a No Brainer Buy?

Stock News•1 hour ago

Micron (MU) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Nvidia's $20 Billion Groq Bet Is Going Live Before the End of 2026. Here's What It Means for Investors.

Stock News•1 hour ago

What Does the FDA's NDA Acceptance Mean for Mineralys Therapeutics

Exclusive Content for Pro Members

Related Articles

What Does Teva's Recent FDA Acceptance Mean for Investors

What Does the FDA's BLA Acceptance Mean for Inhibrx

What Does FDA Clearance Mean for AI-Powered Diagnostics

What Does Ultragenyx's Latest FDA Clearance Mean for Investors

Category

You may also like

Cadence's HypertensionOS Software Announced as Second Participant in FDA's TEMPO to Advance Hypertension Care

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Can Novartis' Fabhalta Strengthen Its Nephrology Franchise?

Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Between Amazon, Alphabet, and Meta, Microsoft is Most Likely to Deliver Best Free Cash Flow in 2026

Amazon Web Services Backlog Reaches $496 Billion: Does That Make Amazon Stock a No Brainer Buy?

Micron (MU) Falls More Steeply Than Broader Market: What Investors Need to Know

Nvidia's $20 Billion Groq Bet Is Going Live Before the End of 2026. Here's What It Means for Investors.

Q2 Earnings Season Winds Down: 3 Companies That Broke Records